Production (Stage)
Generation Bio Co.
GBIO
$0.3706
-$0.0124-3.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 24.56M | 19.89M | 18.58M | 13.17M | 9.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.56M | 19.89M | 18.58M | 13.17M | 9.96M |
| Cost of Revenue | 48.71M | 47.77M | 57.14M | 63.71M | 69.10M |
| Gross Profit | -24.16M | -27.88M | -38.56M | -50.54M | -59.14M |
| SG&A Expenses | 50.08M | 51.59M | 58.99M | 61.66M | 65.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 98.79M | 99.37M | 116.13M | 125.37M | 134.36M |
| Operating Income | -74.24M | -79.47M | -97.55M | -112.19M | -124.40M |
| Income Before Tax | -71.93M | -131.67M | -145.47M | -158.43M | -169.06M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -71.93 | -131.67 | -145.47 | -158.43 | -169.06 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -71.93M | -131.67M | -145.47M | -158.43M | -169.06M |
| EBIT | -74.24M | -79.47M | -97.55M | -112.19M | -124.40M |
| EBITDA | -69.48M | -74.54M | -92.47M | -107.00M | -119.16M |
| EPS Basic | -1.08 | -1.98 | -2.19 | -2.39 | -2.56 |
| Normalized Basic EPS | -0.61 | -0.65 | -0.81 | -0.94 | -1.06 |
| EPS Diluted | -1.08 | -1.98 | -2.19 | -2.39 | -2.56 |
| Normalized Diluted EPS | -0.61 | -0.65 | -0.81 | -0.94 | -1.06 |
| Average Basic Shares Outstanding | 267.06M | 266.49M | 265.77M | 264.93M | 264.06M |
| Average Diluted Shares Outstanding | 267.06M | 266.49M | 265.77M | 264.93M | 264.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |